Hims & Hers Health vs Idexx Laboratories

Side-by-side comparison of AI visibility scores, market position, and capabilities

Idexx Laboratories leads in AI visibility (94 vs 35)
Hims & Hers Health logo

Hims & Hers Health

EmergingHealthcare

General

Telehealth platform with $872M 2024 revenue; GLP-1 weight loss, hair, and sexual health prescriptions shipped directly to 2M+ subscribers; went public via SPAC merger in 2021; compounded medications and same-day shipping differentiate from traditional telehealth.

AI VisibilityBeta
Overall Score
D35
Category Rank
#841 of 1158
AI Consensus
70%
Trend
up
Per Platform
ChatGPT
31
Perplexity
38
Gemini
26

About

Hims & Hers Health is a telehealth and wellness platform offering personalized treatment plans and prescription medications for conditions including hair loss, erectile dysfunction, weight management, skincare, and mental health. Founded in 2017 and headquartered in San Francisco, Hims & Hers went public via SPAC merger in January 2021 and has grown into a $1B+ revenue publicly traded health company. The platform connects patients with licensed providers asynchronously and ships prescription treatments directly to homes, eliminating the friction of in-person doctor visits for lifestyle health conditions.

Full profile
Idexx Laboratories logo

Idexx Laboratories

LeaderHealthcare Tech

Enterprise

Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.

AI VisibilityBeta
Overall Score
A94
Category Rank
#19 of 290
AI Consensus
71%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
92
Gemini
88

About

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.

Full profile

AI Visibility Head-to-Head

35
Overall Score
94
#841
Category Rank
#19
70
AI Consensus
71
up
Trend
stable
31
ChatGPT
99
38
Perplexity
92
26
Gemini
88
35
Claude
94
28
Grok
99

Key Details

Category
General
Enterprise
Tier
Emerging
Leader
Entity Type
company
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.